Related Experiment Video
Updated: Jul 29, 2025

Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
C3 glomerulopathy
Ali Mehdi1, Jonathan J Taliercio2
1Department of Kidney Medicine, Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH; Assistant Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH MEHDIA@ccf.org.
Insights
C3 glomerulopathy (C3G) is a rare kidney disease caused by complement dysregulation. Improved understanding and evidence are crucial for treating this condition with poor prognosis.
Area of Science:
- Nephrology
- Immunology
- Complement System Biology
Background:
- C3 glomerulopathy (C3G) is a rare kidney disease characterized by complement system alternate pathway (AP) dysregulation.
- It includes C3 glomerulonephritis and dense deposit disease, presenting variably and requiring kidney biopsy for diagnosis.
- C3G has a poor prognosis with high post-transplant recurrence rates.
Purpose of the Study:
- To highlight the need for a deeper understanding of C3G pathophysiology.
- To emphasize the requirement for high-quality evidence to guide therapeutic strategies.
- To review current treatment approaches for C3G.
Main Methods:
- Literature review on C3G pathophysiology and current treatments.
- Analysis of diagnostic criteria and prognostic factors.
- Examination of therapeutic options including immunosuppression and complement inhibition.
Main Results:
- C3G results from dysregulation of the complement AP.
- Diagnosis relies on kidney biopsy due to variable presentation.
- Current therapies include mycophenolate mofetil, steroids, and anti-C5 therapy for refractory cases.
Conclusions:
- Further research is essential to elucidate C3G mechanisms.
- High-quality evidence is needed to optimize C3G treatment protocols.
- Effective management of C3G requires a comprehensive approach addressing complement dysregulation.
Abstract:
C3 glomerulopathy (C3G) is a rare kidney disease that causes kidney dysfunction as a result of dysregulation of the complement system alternate pathway (AP). C3G encompasses 2 separate disorders, C3 glomerulonephritis and dense deposit disease. The presentation and natural history is variable and kidney biopsy is needed to confirm the diagnosis. The overall prognosis is poor with high recurrence rates after transplant. A better understanding of C3G is needed as is high-quality evidence to guide therapy, which currently includes mycophenolate mofetil and steroids for moderate to severe disease, and terminal complement blockade with anti-C5 therapy in unresponsive cases.
Related Concept Videos
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Chronic Kidney Disease III: Interprofessional Care
Nephrotic Syndrome I : Introduction
Glaucoma: Overview
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Chronic Kidney Disease II: Clinical Manifestations

